Filing Analysis
Alpha Cognition Inc. appointed Bethany Sensenig to its Board of Directors on April 15, 2026. Ms. Sensenig brings extensive biopharmaceutical experience, having previously served as CFO of Radius Health and in various leadership roles at Biogen.
Key Facts
- Bethany Sensenig was appointed as a director effective April 15, 2026.
- Ms. Sensenig received an initial grant of 5,489 restricted stock units and 6,991 stock options with an exercise price of $6.65.
- Her professional background includes serving as CFO and Head of Operations at Radius Health (2024-2026) and 13 years at Biogen Inc.
- She currently serves on the boards of Supernus Pharmaceuticals (NASDAQ: SUPN) and KalVista Pharmaceuticals (NASDAQ: KALV).
Alpha Cognition Inc. entered into a settlement agreement with Galantos Pharma to buyout all future royalty and milestone obligations related to the Memogain asset for a one-time payment of EUR 5,214,220.
Red Flags
- Significant cash outlay of approximately EUR 5.2 million may impact short-term liquidity for a micro-cap entity.
Key Facts
- Agreement signed on April 10, 2026, with Galantos Pharma GmbH i.L., a company in liquidation.
- One-time payment of EUR 5,214,220 to extinguish all remaining contingent royalty and milestone-related payments.
- The settlement amount represents an approximate 40% discount to the estimated market value of future obligations.
- The agreement relates to the original Memogain Asset Purchase Agreement dated August 23, 2013.
Alpha Cognition Inc. has scheduled its 2026 Annual General Meeting of Shareholders for June 16, 2026. The company established April 24, 2026, as the record date for shareholders entitled to vote at the meeting.
Key Facts
- Annual General Meeting (AGM) date set for June 16, 2026.
- Record date for shareholder voting set for April 24, 2026.
- Notice of Meeting and Record Date filed with Canadian Securities Regulatory Authorities on March 27, 2026.
- The company is a British Columbia corporation listed on the Nasdaq Stock Market (ACOG).
Alpha Cognition Inc. announced its financial and operational results for the fiscal year ended December 31, 2025. The company also scheduled a management call to discuss these results.
Key Facts
- Financial results reported for the fiscal year ended December 31, 2025.
- Press release issued on March 26, 2026.
- Management call announced to discuss operational and financial performance.
- The filing was made under Item 2.02 (Results of Operation and Financial Condition).
Alpha Cognition Inc. announced that Director Len Mertz will not stand for re-election at the 2026 annual meeting. Mr. Mertz will continue to serve on the Board until his current term expires at the meeting.
Key Facts
- Director Len Mertz notified the Board of his decision on February 18, 2026.
- The departure is effective as of the Company’s 2026 Annual Meeting.
- The Company stated there were no disagreements regarding operations, policies, or practices.
- Mr. Mertz will remain in his role until the expiration of his current term.